Teva credit rating downgraded to junk status at Moody’s

“Teva Pharmaceuticals Industries Ltd.’s TEVA, +1.77% credit rating was downgraded two notches into junk status at Moody’s Investors Service, which cited concerns over the drug maker’s sizable debt” writes Reporter Editor for Teva’s credit is also rated junk at Fitch Ratings, but S&P Global Ratings rates it BBB-, which is its lowest investment grade rating.

Share This:

Related posts